Prophylaxe und Therapie der diabetischen Nephropathie

Christiane Kettner(Friedrich Schiller University Jena), Johannes F.E. Mann

Der Nephrologe

September 8, 2017

10.1007/s11560-017-0193-3

Cited by 1

Abstract

Related Papers

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Hertzel C Gerstein, Hertzel C. Gerstein, Michael E. Miller et al.|New England Journal of Medicine|2008|7.9k

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

Anushka Patel, Anushka Patel, Stephen MacMahon et al.|New England Journal of Medicine|2008|7.4k

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al.|New England Journal of Medicine|2001|6k

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

|The Lancet|2000|3.2k

Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite

Karine Spiegel, Esra Tasali, Plamen D. Penev et al.|Annals of Internal Medicine|2004|2.4k